leucine has been researched along with Wasting Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birzniece, V; Handelsman, DJ; Ho, KK; Poljak, A; Umpleby, MA | 1 |
| Chen, Y; McIntire, K; Rabkin, R; Roth, R; Sood, S | 1 |
| Frost, RA; Huber, D; Lang, CH | 1 |
| Fareed, M; Hasselgren, PO; Menconi, M; O'Neal, P; Poylin, V; Wei, W | 1 |
| Boden, G; Leskiw, MJ; Schluter, MD; Stein, TP | 1 |
| Deutz, NE; Engelen, MP; Schols, AM; Wouters, EF | 1 |
| Bevington, A; Brown, J; Walls, J | 1 |
1 review(s) available for leucine and Wasting Disease
| Article | Year |
|---|---|
Role of glucocorticoids in the molecular regulation of muscle wasting.
Topics: Animals; CCAAT-Enhancer-Binding Proteins; Forkhead Transcription Factors; Glucocorticoids; Humans; Insulin; Insulin-Like Growth Factor I; Leucine; Muscle Proteins; Muscle, Skeletal; Nuclear Proteins; Proteasome Endopeptidase Complex; Ubiquitins; Wasting Syndrome | 2007 |
2 trial(s) available for leucine and Wasting Disease
| Article | Year |
|---|---|
Oral low-dose testosterone administration induces whole-body protein anabolism in postmenopausal women: a novel liver-targeted therapy.
Topics: Administration, Oral; Aged; Anabolic Agents; Androgens; Energy Metabolism; Female; Humans; Insulin-Like Growth Factor I; Leucine; Liver; Middle Aged; Oxidation-Reduction; Postmenopause; Proteins; Proteolysis; Sarcopenia; Sex Hormone-Binding Globulin; Testosterone; Transaminases; Wasting Syndrome | 2013 |
Attenuation of the protein wasting associated with bed rest by branched-chain amino acids.
Topics: Adult; Amino Acids; Amino Acids, Branched-Chain; Bed Rest; Energy Metabolism; Female; Food, Formulated; Humans; Isoleucine; Leucine; Male; Methylhistidines; Muscle Proteins; Nitrogen; Valine; Wasting Syndrome | 1999 |
4 other study(ies) available for leucine and Wasting Disease
| Article | Year |
|---|---|
Leucine-stimulated mTOR signaling is partly attenuated in skeletal muscle of chronically uremic rats.
Topics: Animals; Chronic Disease; Drug Evaluation, Preclinical; Kidney; Kidney Failure, Chronic; Leucine; Male; Muscle, Skeletal; Muscular Diseases; Rats; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases; Uremia; Wasting Syndrome; Weight-Bearing | 2011 |
Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I.
Topics: Animals; Blotting, Northern; Boronic Acids; Bortezomib; Burns; Down-Regulation; Glucocorticoids; Hormone Antagonists; Immunoblotting; Insulin-Like Growth Factor I; Leucine; Male; Mifepristone; Muscle Proteins; Muscle, Skeletal; Myocardium; Organ Size; Polyubiquitin; Protein Synthesis Inhibitors; Pyrazines; Rats; Rats, Wistar; RNA, Messenger; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin; Ubiquitin-Protein Ligases; Wasting Syndrome | 2007 |
Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease.
Topics: Aged; Amino Acids; Carbon Radioisotopes; Female; Humans; Leucine; Lung Diseases, Obstructive; Male; Middle Aged; Predictive Value of Tests; Proteins; Wasting Syndrome; Whole-Body Counting | 2000 |
Leucine suppresses acid-induced protein wasting in L6 rat muscle cells.
Topics: Acidosis; Animals; Caprylates; Cell Line; Fatty Acids, Nonesterified; Glycolysis; Hydrogen-Ion Concentration; Leucine; Muscle Proteins; Muscle, Skeletal; Rats; Wasting Syndrome | 2001 |